Diane Caruana
Why is the UK Turning Its Back on Its Own Successful...
For over a decade the UK was the global anchor example of evidence-based tobacco harm reduction. University academics, economists and THR advocates worldwide cited...
How Cultural Frames Shape Tobacco Harm Reduction (or Lack Of) in...
As numerous Asian countries move further towards restricting novel nicotine products, it becomes clearer that across Asia, the policy trend around products such as...
A Subtle But Vital Shift: The EU Softens Its Position On...
With COP11 now imminent in Geneva, a very unexpected development inside Brussels has shifted tone and energy across the European harm reduction world. After...
The Second Life of Juul: Why the Brand’s Return Matters for...
For the first time after being cast in the shadows, Juul Labs appears to be launching a strategic reset. The company — once valued...
Two Major Powers With Contrasting Plans for COP11: Does THR Stand...
As delegates gather in Geneva for the infamous 11th Conference of the Parties (COP-11) to the World Health Organization’s Framework Convention on Tobacco Control...
Innovation Over Ideology: The Launch of a Science Driven New Nicotine...
Users can achieve satisfaction with roughly 40% less total nicotine over a typical 24-minute session, potentially reducing overall intake without compromising experience.As global tobacco...
France’s War on Vaping: Inside the 2026 Finance Bill That Threatens...
France is set to enact sweeping changes through its 2026 Finance Bill that would significantly alter the vape market. Amongst other things, the proposed...
The WHO’s Blind Spot: The Latest Concerns Related to the Upcoming...
As governments prepare for the World Health Organization’s (WHO) 11th Conference of the Parties (COP11) to the Framework Convention on Tobacco Control (FCTC) this...









